PuSH - Publikationsserver des Helmholtz Zentrums München

Stem cell-derived islet therapy: Is this the end of the beginning?

Nat. Rev. Endocrinol. 19, 681-682 (2023)
DOI PMC
The debut of stem cell-derived islets in the clinic for glycaemic control in patients with type 1 diabetes mellitus has garnered much excitement. Ongoing research in this field guarantees to be transformative for modern treatment of diabetes mellitus.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Letter to the Editor
Korrespondenzautor
ISSN (print) / ISBN 1759-5029
e-ISSN 1759-5037
Quellenangaben Band: 19, Heft: 12, Seiten: 681-682 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort New York, NY
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institut f. Diabetes u. Organoidtech (IDOT)